Fluorescent in situ hybridization (FISH), immunohistochemistry (IHC), and sequencing of DNA and RNA are standard methods to detect ALK and ROS1 fusions, but they are costly, time-consuming, and require adequate tumor tissue. This evidence concerns the gene ROS1 and neoplasm.